Lung Epithelial-Mesenchymal Interactions in Adenocarcinoma Invasion
腺癌侵袭中的肺上皮-间质相互作用
基本信息
- 批准号:8319725
- 负责人:
- 金额:$ 3.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-01-01 至 2011-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenocarcinomaAdenovirusesAllelesAlveolar wallAnimal ModelApoptosisApplications GrantsBasement membraneBioinformaticsBiologicalBiological AssayBreastBronchiolo-Alveolar AdenocarcinomaCCR5 geneCXC ChemokinesCancer HistologyCell surfaceCell-Cell AdhesionCellsCellular MorphologyCharacteristicsClinicalCoculture TechniquesCodon NucleotidesDevelopmentDiseaseDown-RegulationEpithelialEpithelial CellsEpithelial-Stromal CommunicationEpitheliumEventFibroblastsFrequenciesGene ExpressionGene Expression ProfilingGenesGenetic ModelsGoalsHeterogeneityHistologyHumanIn VitroIncidenceIndividualInvadedKnock-outLungLung AdenocarcinomaMalignant Epithelial CellMalignant NeoplasmsMalignant neoplasm of lungMediatingMediator of activation proteinMesenchymalMicroarray AnalysisModelingMolecularMolecular ProfilingMorphologyMucinsMusMutant Strains MiceMutationNeoplasm MetastasisNodalOncogenicOutcomePathological StagingPathway interactionsPatientsPatternPhenotypePrincipal InvestigatorProcessProductionProteinsRANTESRelative (related person)RepressionResearch PersonnelRoleSignal TransductionSpecimenStagingStaining methodStainsStromal CellsStromal NeoplasmSurvival RateSystemTGFB1 geneTGFBR2 geneTestingTissue MicroarrayTissuesTransforming Growth FactorsWild AnimalsWorld Health Organizationadverse outcomeangiogenesisbasecell growthcell motilitycell stromaclinically significantcohortexpectationfollow-uphigh riskhuman datain vivoinhibitor/antagonistinterestknock-downlung Carcinomamatrigelmeetingsmouse modelmutantneoplastic cellnovelpreventprogramsreceptorrecombinaseresearch studytumor
项目摘要
Within lung adenocarcinoma, histology is heterogeneous and associated with tissue invasion and clinical
outcomes. The spectrum of intra-tumoral histological heterogeneity in adenocarcinoma suggests
nvasiveness represents a continuum of disease from noninvasive bronchioloalveolar carcinoma (BAG) to
adenocarcinoma mixed subtype with BAG component to pure invasive adenocarcinoma. The molecular
events essential to this transition in the lung are presently unknown. In this study, we focus on invasion, a
significant biological and morphological characteristic of cancer with direct clinical implications in terms of
metastasis and outcome. In preliminary gene expression profiling experiments, we identified the type II TGF-
/? receptor (TGF/SRII), which was expressed at significantly lower levels in invasive tumors, as one of the
most interesting genes in the acquisition of lung invasiveness classifiers. We hypothesize that repression of
TGFBRII in lung adenocarcinoma is required to mediate tumor/stromal interactions that precede the
acquisition of invasiveness in lung adenocarcinoma. In this grant proposal, we will address the main
hypothesis in the following Specific aims: 1. Determine the direct role of Tgfbr2 repression on
adenocarcinoma invasiveness in vivo using genetic model of murine lung adenocarcinoma. We will create a
novel animal model of invasive lung adenocarcinoma in mice with pulmonary targeted deletion of Tgfbr2 and
mutation of K-Ras. In Aim 2, we will determine the requirement for CCL5 (Rantes) in mediating tumor-
stromal interactions that are important for invasion of TGFBRII knock-down cells. CCL5 was identified as a
potential downstream mediator of TGFB signaling in invasive tumors. In Aim 3, we will create a large
adenocarcinoma tumor microarray to examine the clinical significance of TGFBRII immunostaining human
lung adenocarcinoma. In these studies, we will demonstrate the importance of TGFBR2 pathways in
modulating tumor epithelial/stromal interactions important for the acquisition of invasiveness in lung
adenocarcinoma and we expect to identify the mechanisms of this activity. The results of these studies will
facilitate the attainment of the long-term goals, which are to develop clinically available assays to predict
invasive propensity in adenocarcinoma tissue specimens and to develop and test pharmacologic agents that
will reduce invasiveness in patients with lung cancer or prevent the development of invasive tumors in
individuals at high risk for lung cancer.
在肺腺癌中,组织学是异质的,并且与组织侵袭和临床相关。
结果。腺癌瘤内组织学异质性谱表明
侵袭性代表从非侵袭性细支气管肺泡癌 (BAG) 到
具有BAG成分的腺癌混合亚型到纯浸润性腺癌。分子
目前尚不清楚肺部这种转变所必需的事件。在这项研究中,我们关注的是入侵,
癌症的重要生物学和形态学特征,具有直接的临床意义
转移和结果。在初步的基因表达谱实验中,我们鉴定出 II 型 TGF-
/?受体(TGF/SRII),其在侵袭性肿瘤中的表达水平显着较低,是一种
获取肺侵袭性分类器中最有趣的基因。我们假设压制
肺腺癌中的 TGFBRII 需要介导肿瘤/基质相互作用,
肺腺癌获得侵袭性。在本拨款提案中,我们将解决主要问题
具体目标如下: 1. 确定 Tgfbr2 抑制对
使用小鼠肺腺癌的遗传模型研究腺癌的体内侵袭性。我们将创建一个
肺靶向删除Tgfbr2和小鼠的侵袭性肺腺癌新动物模型
K-Ras 突变。在目标 2 中,我们将确定 CCL5 (Rantes) 在介导肿瘤中的需求
基质相互作用对于 TGFBRII 敲低细胞的侵袭很重要。 CCL5 被鉴定为
侵袭性肿瘤中 TGFB 信号传导的潜在下游介质。在目标 3 中,我们将创建一个大型
腺癌肿瘤微阵列检测人TGFBRII免疫染色的临床意义
肺腺癌。在这些研究中,我们将证明 TGFBR2 通路在
调节肿瘤上皮/基质相互作用对于获得肺部侵袭性很重要
腺癌,我们希望确定这种活性的机制。这些研究的结果将
促进实现长期目标,即开发临床可用的检测方法来预测
腺癌组织标本的侵袭倾向,并开发和测试药物
将减少肺癌患者的侵袭性或预防侵袭性肿瘤的发展
肺癌高危人群。
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tgf-beta signaling pathway in lung adenocarcinoma invasion.
- DOI:10.1097/jto.0b013e3181c8cc0c
- 发表时间:2010-02
- 期刊:
- 影响因子:0
- 作者:Toonkel RL;Borczuk AC;Powell CA
- 通讯作者:Powell CA
Waiting to exhale.
等待呼气。
- DOI:10.1164/rccm.200710-1604ed
- 发表时间:2008
- 期刊:
- 影响因子:24.7
- 作者:Powell,CharlesAndrew
- 通讯作者:Powell,CharlesAndrew
Do all lung adenocarcinomas follow a stepwise progression?
- DOI:10.1016/j.lungcan.2011.05.021
- 发表时间:2011-10
- 期刊:
- 影响因子:5.3
- 作者:Yatabe, Yasushi;Borczuk, Alain C.;Powell, Charles A.
- 通讯作者:Powell, Charles A.
Carcinoma of the lung and metastatic disease of the central nervous system.
肺癌和中枢神经系统转移性疾病。
- DOI:10.1164/ajrccm.178.10.1090
- 发表时间:2008
- 期刊:
- 影响因子:24.7
- 作者:Austin,JohnHM;Mujoomdar,Amol;Powell,CharlesA;Pearson,GregoryDN;Raftopoulos,Harry
- 通讯作者:Raftopoulos,Harry
Invasive size is an independent predictor of survival in pulmonary adenocarcinoma.
- DOI:10.1097/pas.0b013e318190157c
- 发表时间:2009-03
- 期刊:
- 影响因子:0
- 作者:Borczuk AC;Qian F;Kazeros A;Eleazar J;Assaad A;Sonett JR;Ginsburg M;Gorenstein L;Powell CA
- 通讯作者:Powell CA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles A. Powell其他文献
Cell–cell communication: old mystery and new opportunity
- DOI:
10.1007/s10565-019-09470-y - 发表时间:
2019-02-27 - 期刊:
- 影响因子:5.900
- 作者:
Dongli Song;Dawei Yang;Charles A. Powell;Xiangdong Wang - 通讯作者:
Xiangdong Wang
Schoolwide Impact and AVID: How Have Selected Texas High Schools Addressed the New Accountability Measures?
全校影响和 AVID:德克萨斯州部分高中如何应对新的问责措施?
- DOI:
10.1207/s15327671espr1101_4 - 发表时间:
2006 - 期刊:
- 影响因子:0
- 作者:
K. Watt;Charles A. Powell;Irma Doris Mendiola;Griselda Cossio - 通讯作者:
Griselda Cossio
Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer
- DOI:
10.1007/s10549-020-05754-8 - 发表时间:
2020-06-26 - 期刊:
- 影响因子:3.000
- 作者:
Michelle D. Hackshaw;Heather E. Danysh;Jasmeet Singh;Mary E. Ritchey;Amy Ladner;Corina Taitt;D. Ross Camidge;Hiroji Iwata;Charles A. Powell - 通讯作者:
Charles A. Powell
Characterization and Antibacterial Activity of Oil-In-Water Nano-Emulsion Formulation Against Candidatus Liberibacter asiaticus.
水包油纳米乳液制剂对亚洲自由杆菌的表征和抗菌活性。
- DOI:
10.1094/pdis-05-16-0600-re - 发表时间:
2016 - 期刊:
- 影响因子:4.5
- 作者:
C. Y. Yang;Charles A. Powell;Yongping Duan;Muqing Zhang - 通讯作者:
Muqing Zhang
Novel paradigms of macrophage biology and function: identification of disease biomarkers and therapeutic targets
- DOI:
10.1007/s10565-022-09749-7 - 发表时间:
2022-07-18 - 期刊:
- 影响因子:5.900
- 作者:
Diane Catherine Wang;Xuanqi Liu;Charles A. Powell;Xiangdong Wang - 通讯作者:
Xiangdong Wang
Charles A. Powell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles A. Powell', 18)}}的其他基金
Endothelial cell-derived MMP14 in lung alveolar regeneration and fibrosis
内皮细胞衍生的 MMP14 在肺泡再生和纤维化中的作用
- 批准号:
10022328 - 财政年份:2016
- 资助金额:
$ 3.8万 - 项目类别:
Lung Epithelial-Mesenchymal Interactions in Adenocarcinoma Invasion
腺癌侵袭中的肺上皮-间质相互作用
- 批准号:
7738519 - 财政年份:2007
- 资助金额:
$ 3.8万 - 项目类别:
Lung Epithelial-Mesenchymal Interactions in Adenocarcinoma Invasion
腺癌侵袭中的肺上皮-间质相互作用
- 批准号:
7213198 - 财政年份:2007
- 资助金额:
$ 3.8万 - 项目类别:
Lung Epithelial-Mesenchymal Interactions in Adenocarcinoma Invasion
腺癌侵袭中的肺上皮-间质相互作用
- 批准号:
8004958 - 财政年份:2007
- 资助金额:
$ 3.8万 - 项目类别:
Lung Epithelial-Mesenchymal Interactions in Adenocarcinoma Invasion
腺癌侵袭中的肺上皮-间质相互作用
- 批准号:
7334742 - 财政年份:2007
- 资助金额:
$ 3.8万 - 项目类别:
Lung Epithelial-Mesenchymal Interactions in Adenocarcinoma Invasion
腺癌侵袭中的肺上皮-间质相互作用
- 批准号:
7538365 - 财政年份:2007
- 资助金额:
$ 3.8万 - 项目类别:
MOLECULAR ALTERATIONS IN EPITHELIAL CELLS OF SMOKERS
吸烟者上皮细胞的分子变化
- 批准号:
6567819 - 财政年份:2001
- 资助金额:
$ 3.8万 - 项目类别:
MOLECULAR ALTERATIONS IN EPITHELIAL CELLS OF SMOKERS
吸烟者上皮细胞的分子变化
- 批准号:
6468557 - 财政年份:2000
- 资助金额:
$ 3.8万 - 项目类别:
SUSCEPTIBILITY TO MOLECULAR ALTERATION: EPITHELIAL CELLS
对分子改变的敏感性:上皮细胞
- 批准号:
6524698 - 财政年份:1999
- 资助金额:
$ 3.8万 - 项目类别:
SUSCEPTIBILITY TO MOLECULAR ALTERATION--EPITHELIAL CELLS
对分子改变的敏感性——上皮细胞
- 批准号:
6031932 - 财政年份:1999
- 资助金额:
$ 3.8万 - 项目类别:
相似国自然基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
- 批准号:30840003
- 批准年份:2008
- 资助金额:12.0 万元
- 项目类别:专项基金项目
相似海外基金
Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
- 批准号:
478914 - 财政年份:2023
- 资助金额:
$ 3.8万 - 项目类别:
Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
- 批准号:
23K14913 - 财政年份:2023
- 资助金额:
$ 3.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
- 批准号:
23K15035 - 财政年份:2023
- 资助金额:
$ 3.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
- 批准号:
10657069 - 财政年份:2023
- 资助金额:
$ 3.8万 - 项目类别:
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
- 批准号:
10442874 - 财政年份:2023
- 资助金额:
$ 3.8万 - 项目类别:
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
- 批准号:
23H02698 - 财政年份:2023
- 资助金额:
$ 3.8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
- 批准号:
23K08326 - 财政年份:2023
- 资助金额:
$ 3.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
- 批准号:
23K14614 - 财政年份:2023
- 资助金额:
$ 3.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
- 批准号:
23K15075 - 财政年份:2023
- 资助金额:
$ 3.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
- 批准号:
10743611 - 财政年份:2023
- 资助金额:
$ 3.8万 - 项目类别:














{{item.name}}会员




